The challenging times and opportunities for pharmacovigilance in Africa during the COVID-19 pandemic [0.03%]
COVID-19大流行期间非洲药物警戒面临的挑战和机遇
C Ogar,W Mathenge,C Khaemba et al.
C Ogar et al.
Current pharmacy practices in low- and middle-income countries; recommendations in response to the COVID-19 pandemic [0.03%]
低收入和中等收入国家当前的药房实践；针对COVID-19大流行的建议
Husnain Hamid,Rizwan Ali Masood,Hira Tariq et al.
Husnain Hamid et al.
Within a large healthcare system, the incidence of positive COVID-19 results and mortality are lower in patients on chronic hydroxychloroquine therapy [0.03%]
在大型医疗系统中，长期使用羟氯喹的患者新冠病毒检测阳性率和死亡率较低
Soma Sen,Ann Werner,Aditya Shekhar
Soma Sen
Knowledge, attitude and preventive practices related to COVID-19: a cross-sectional study in two Pakistani university populations [0.03%]
巴基斯坦两所大学人群的新冠肺炎相关知识、态度和预防行为：横断面研究
Muhammad Salman,Zia Ul Mustafa,Noman Asif et al.
Muhammad Salman et al.
Objective: The aim of this study was to assess COVID-19-related knowledge, attitudes, and preventive practices of two Pakistani university populations. Me...
Is Pakistan on track to have COVID-19 transmission and mortality rates similar to those of Italy, Iran or the USA? [0.03%]
巴基斯坦的新冠疫情传播和死亡率会像意大利、伊朗或美国那样严重吗？
Bilal Javed,Abdullah Sarwer,Erik B Soto et al.
Bilal Javed et al.
Sitaram Khadka,Furqan K Hashmi,Muhammad Usman
Sitaram Khadka
Sumaira Omer,Salamat Ali,Zaheer Ud Din Babar
Sumaira Omer
High-dose hydroxocobalamin in end-stage liver disease and liver transplantation [0.03%]
终期肝病和肝脏移植患者的高剂量氢钴胺素治疗
Sujit Vijay Sakpal,Hannah Reedstrom,Cody Ness et al.
Sujit Vijay Sakpal et al.
Distributive shock is a serious complication in patients with chronic or end-stage liver disease, and can be exacerbated by vasoplegia in this patient population. Vasoplegic syndrome (VS) is a state of shock refractory to catecholamines and...
Negar Golchin,Hannah Johnson,Paul M Bakaki et al.
Negar Golchin et al.
Introduction: Various methods have been used to interpret the reports of pediatric polypharmacy across the literature. This is the first scoping review that explores outcome measures in pediatric polypharmacy research. ...